In vitro evaluation of the antibacterial activity of extracts from 34 species of North American lichens

Pharmaceutical Biology

Volumn 52, Issue 10, 2014, Pages 1262-1266

  Shrestha, Gajendra ^a   Raphael, Jocelyn ^a   Leavitt, Steven D ^b   St Clair, Larry L ^a  

^a BRIGHAM YOUNG UNIVERSITY   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Antibiotic; MIC; Micro broth dilution; Natural products; TLC

Indexed keywords

ACETONE; ANTIINFECTIVE AGENT; LETHARIA COLUMBIANA EXTRACT; LETHARIA VULPINA EXTRACT; METHANOL; UNCLASSIFIED DRUG; VULPICIDA CANADENSIS EXTRACT; PLANT EXTRACT;

ALECTORIA IMSHAUGII; ALECTORIA SARMENTOSA; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BRYORIA FUSCESCENS; CLADONIA FURCATA; CONTROLLED STUDY; DRUG EFFICACY; DRUG SCREENING; ESCHERICHIA COLI; EVERNIA PRUNASTRI; EVERNIASTRUM CATAWBIENSE; FLAVOCETRARIA NIVALIS; HYPOGYMNIA PHYSODES; IN VITRO STUDY; LETHARIA COLUMBIANA; LETHARIA VULPINA; LICHEN (ORGANISM); LOBARIA PULMONARIA; MASONHALEA RICHARDSONII; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PARMELIA SULCATA; PARMOTREMA RETICULATUM; PELTIGERA APHTHOSA; PLATISMATIA GLAUCA; PSEUDOMONAS AERUGINOSA; RAMALINA SINENSIS; RHIZOPLACA CHRYSOLEUCA; RHIZOPLACA HAYDENII; RHIZOPLACA IDAHOENSIS; RHIZOPLACA MARGINALIS; RHIZOPLACA MELANOPHTHALMA; RHIZOPLACA PELTATA; SPHAEROPHORUS GLOBOSUS; STAPHYLOCOCCUS AUREUS; THAMNOLIA VERMICULARIS; THIN LAYER CHROMATOGRAPHY; TUCKERMANNOPSIS CILIARIS; UMBILICARIA AMERICANA; UMBILICARIA MAMMULATA; USNEA HIRTA; USNEA STRIGOSA; VULPICIDA CANADENSIS; XANTHOPARMELIA CHLOROCHROA; XANTHOPARMELIA COLORADOENSIS; DRUG EFFECTS; GENETICS; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; NORTH AMERICA; PHYSIOLOGY; PROCEDURES; SPECIES DIFFERENCE;

ANTI-BACTERIAL AGENTS; DRUG EVALUATION, PRECLINICAL; LICHENS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; NORTH AMERICA; PLANT EXTRACTS; PSEUDOMONAS AERUGINOSA; SPECIES SPECIFICITY; STAPHYLOCOCCUS AUREUS;

EID: 84907044702     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.3109/13880209.2014.889175     Document Type: Article

References (44)

1. Andersson DI, Hughes D. (2012). Evolution of antibiotic resistance at non-lethal drug concentrations. Drug Resis Updat 15:162-72.
2. Boucher HW, Talbot GH, Bradley JS, et al. (2009). Bad bugs, no drugs: No ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis 48:1-12.
3. Boustie J, Tomasi S, Grube M. (2011). Bioactive lichen metabolites: Alpine habitats as an untapped source. Phytochem Rev 10:287-307.
4. Burkholder PR, Evans AW, Mcveigh I, Thornton HK. (1944). Antibiotic activity of lichens. Proc Natl Acad Sci USA 30:250-5.
5. Cocchietto M, Skert N, Nimis PL, Sava G. (2002). A review on usnic acid, an interesting natural compound. Naturwissenschaften 89: 137-46.
6. Elo H, Matikainen J, Pelttari E. (2007). Potent activity of the lichen antibiotic (+)-usnic acid against clinical isolates of vancomycinresistant enterococci and methicillin-resistant Staphylococcus aureus. Naturwissenschaften 94:465-8.
7. Esslinger TL. (2012). A cumulative checklist for the lichen-forming, lichenicolous and allied fungi of the continental United States and Canada [Online]. Available from: http://www.ndsu.edu/pubweb/~esslinge/chcklst/chcklst7.htm [last assessed 30 Aug 2013].
8. Francolini I, Norris P, Piozzi A, et al. (2004). Usnic acid, a natural antimicrobial agent able to inhibit bacterial biofilm formation on polymer surfaces. Antimicrob Agents Chemother 48:4360-5.
9. Geiser LH, Jovan SE, Glavich DA, Porter MK. (2010). Lichen-based critical loads for atmospheric nitrogen deposition in Western Oregon and Washington Forests, USA. Environ Pollut 158:2412-11.
10. Gulluce M, Aslan A, Sokmen M, et al. (2006). Screening the antioxidant and antimicrobial properties of the lichens Parmelia saxatilis, Platismatia glauca, Ramalina pollinaria, Ramalina polymorpha, and Umbilicaria nylanderiana. Phytomedicine 13:515-21.
11. He H, Bigelis R, Yang HY, et al. (2005). Lichenicolins A and B, new bisnaphthopyrones from an unidentified lichenicolous fungus, strain LL-RB0668. J Antibiot (Tokyo) 58:731-6.
12. Hobbs C. (1986). Usnea: The Herbal Antibiotic and Other Medicinal Lichens. Capitola (CA): Botanica Press.
13. Hoskeri HJ, Krishna V, Amruthavalli C. (2010). Effects of extracts from lichen Ramalina pacifica against clinically infectious bacteria. Researcher 2:81-5.
14. Ingólfsdóttir K. (2002). Usnic acid. Phytochemistry 61:729-36.
15. Ingólfsdóttir K, Bloomfield SF, Hylands PJ. (1985). In vitro evaluation of the antimicrobial activity of lichen metabolites as potential preservatives. Antimicrob Agents Chemother 28:289-92.
16. Kokubun T, Shiu WK, Gibbons S. (2007). Inhibitory activities of lichenderived compounds against methicillin- and multidrug-resistant Staphylococcus aureus. Planta Med 73:176-9.
17. Lauterwein M, Oethinger M, Belsner K, et al. (1995). In vitro activities of the lichen secondary metabolites vulpinic acid, (+)-usnic acid, and (-)-usnic acid against aerobic and anaerobic microorganisms. Antimicrob Agents Chemother 39:2541-3.
18. Lawrey JD. (1989). Lichen secondary compounds: Evidence for a correspondence between antiberbivore and antimicrobial function. Bryologist 92:326-8.
19. Leavitt SD, Esslinger TL, Spribille T, et al. (2012). Multilocus phylogeny of the lichen-forming fungal genus Melanohalea (Parmeliaceae, Ascomycota): Insights on diversity, distributions, and a comparison of species tree and concatenated topologies. Mol Phylogenet Evol 66:138-52.
20. Leavitt SD, St. Clair LL. (2011). Estimating Xanthoparmelia (Parmeliaceae) population density in subalpine communities in southern Utah, USA using two distance methods, with implications for assessing community composition. Bryologist 114:625-36.
21. Leeb M. (2004). Antibiotics: A shot in the arm. Nature 431:892-3.
22. Lendemer JC, Hodkinson BP. (2013). A radical shift in the taxonomy of Lepraria sl: Molecular and morphological studies shed new light on the evolution of asexuality and lichen growth form diversification. Mycologia 105:994-1018.
23. Mann CM, Markham JL. (1998). A new method for determining the minimum inhibitory concentration of essential oils. J Appl Microbiol 84:538-44.
24. Manojlovic NT, Vasiljevic PJ, Maskovic PZ, et al. (2011). Chemical composition, antioxidant, and antimicrobial activities of lichen Umbilicaria cylindrica (L.) Delise (Umbilicariaceae). Evid Based Complement Alternat Med 2012:1-8.
25. Mcmurray JA, Roberts DW, Fenn ME, et al. (2013). Using epiphytic lichens to monitor nitrogen deposition near natural gas drilling operations in the Wind River Range, WY, USA. Water Air Soil Pollut 224:1-14.
26. Melgarejo M, Sterner O, Castro JV, Mollinedo P. (2008). More investigations in potent activity and relationship structure of the lichen antibiotic (+)-usnic acid and its derivate dibenzoylusnic acid. Rev Boliv Quim 25:24-9.
27. Molnar K, Farkas E. (2010). Current results on biological activities of lichen secondary metabolites: A review. Z Naturforsch (C) 65:157-73.
28. Newman DJ, Cragg GM. (2007). Natural products as sources of new drugs over the last 25 years. J Nat Prod 70:461-77.
29. Orange A, James PW, White FJ. (2001). Microchemical Methods for the Identification of Lichens. Slough, UK: British Lichen Society.
30. Paudel B, Bhattarai HD, Lee JS, et al. (2008). Antibacterial potential of antarctic lichens against human pathogenic Gram-positive bacteria. Phytother Res 22:1269-71.
31. Paudel B, Bhattarai HD, Pandey DP, et al. (2012). Antioxidant, antibacterial activity and brine shrimp toxicity test of some Mountainous lichens from Nepal. Biol Res 45:387-91.
32. Podterob AP. (2008). Chemical composition of lichens and their medical applications. Pharm Chem J 42:582-8.
33. Pompilio A, Pomponio S, Di Vincenzo V, et al. (2013). Antimicrobial and antibiofilm activity of secondary metabolites of lichens against methicillin-resistant Staphylococcus aureus strains from cystic fibrosis patients. Future Microbiol 8:281-92.
34. Ranković B, Mišić M, Sukdolak S. (2007). Evaluation of antimicrobial activity of the lichens Lasallia pustulata, Parmelia sulcata, Umbilicaria crustulosa, and Umbilicaria cylindrica. Microbiology 76:723-7.
35. Ranković B, Mišić M, Sukdolak S. (2008). The antimicrobial activity of substances derived from the lichens Physcia aipolia, Umbilicaria polyphylla, Parmelia caperata and Hypogymnia physodes. World J Microbiol Biotechnol 24:1239-42.
36. Rankovič B, Rankovic D, Maric D. (2010). Antioxidant and antimicrobial activity of some lichen species. Microbiology 79:809-15.
37. Saleem M, Nazir M, Ali MS, et al. (2010). Antimicrobial natural products: An update on future antibiotic drug candidates. Nat Prod Rep 27:238-54.
38. Shrestha G, Petersen SL, St. Clair LL. (2012). Predicting the distribution of the air pollution sensitive lichen species Usnea hirta. Lichenologist 44:511-21.
39. Shrestha G, St. Clair LL. (2013a). Lichens: A promising source of antibiotic and anticancer drugs. Phytochem Rev 12:229-44.
40. Shrestha G, St. Clair LL. (2013b). Antimicrobial activity of extracts from two lichens Ramalina menziesii and Usnea lapponica. Bull Cali Lich Soc 20:5-10.
41. Shukla V, Joshi G, Rawat MSM. (2010). Lichens as a potential natural source of bioactive compounds: A review. Phytochem Rev 9: 303-14.
42. Srivastava P, Upreti DK, Dhole TN, Srivastava AK. (2013). In-vitro evaluation of the antimicrobial activities of lichen Usnea ghattensis. Int J Curr Microbiol Appl Sci 2:271-9.
43. Turk AO, Yilmaz M, Kivanc M, Turk H. (2003). The antimicrobial activity of extracts of the lichen Cetraria aculeata and its protolichesterinic acid constituent. Z Naturforsch C, J Biosci 58: 850-4.
44. Yilmaz M, Tay T, Kivanc M, et al. (2005). The antimicrobial activity of extracts of the lichen Hypogymnia tubulosa and its 3-hydroxyphysodic acid constituent. Z Naturforsch C, J Biosci 60:35-8.